Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington’s disease

[1]  Dimitri Krainc,et al.  Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease , 2002, Science.

[2]  A. Dale,et al.  Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.

[3]  C. Cepeda,et al.  Changes in Cortical and Striatal Neurons Predict Behavioral and Electrophysiological Abnormalities in a Transgenic Murine Model of Huntington's Disease , 2001, The Journal of Neuroscience.

[4]  J. Dreyer,et al.  Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. , 2001, Journal of cell science.

[5]  Elena Cattaneo,et al.  Loss of normal huntingtin function: new developments in Huntington's disease research , 2001, Trends in Neurosciences.

[6]  J. Mazzola,et al.  Reduction of glyceraldehyde‐3‐phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts , 2001, Journal of neurochemistry.

[7]  D. Tagle,et al.  Normal and mutant huntingtin: Partners in crime? , 2000, Nature Medicine.

[8]  Y. Kawaoka,et al.  Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice , 2000, Nature Medicine.

[9]  S. W. Davies,et al.  Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Hersch,et al.  Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease , 2000, Nature Medicine.

[11]  K. Birmingham.  No dismissal for hate-mail author , 2000, Nature Medicine.

[12]  A. Boulton,et al.  Glyceraldehyde‐3‐phosphate dehydrogenase and apoptosis , 2000, Journal of neuroscience research.

[13]  A. Cooper,et al.  The selective vulnerability of striatopallidal neurons , 1999, Progress in Neurobiology.

[14]  D. Chuang,et al.  Involvement of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and p53 in Neuronal Apoptosis: Evidence That GAPDH Is Upregulated by p53 , 1999, The Journal of Neuroscience.

[15]  B. Hu,et al.  Ethidium bromide staining reveals rapid cell dispersion in the rat dentate gyrus following ouabain-induced injury , 1999, Neuroscience.

[16]  M A Sirover,et al.  New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. , 1999, Biochimica et biophysica acta.

[17]  D. Tagle,et al.  Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[18]  J. Penney,et al.  Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease , 1999, Nature.

[19]  Claire-Anne Gutekunst,et al.  A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration , 1999, Neuron.

[20]  P. Brundin,et al.  Recent Advances on the Pathogenesis of Huntington's Disease , 1999, Experimental Neurology.

[21]  S. Sealfon,et al.  Nuclear translocation of GAPDH-GFP fusion protein during apoptosis. , 1999, Neuroreport.

[22]  D. Chuang,et al.  Nuclear Translocation of Glyceraldehyde‐3‐Phosphate Dehydrogenase Isoforms During Neuronal Apoptosis , 1999, Journal of neurochemistry.

[23]  D. Borchelt,et al.  Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. , 1999, Human molecular genetics.

[24]  B. McEwen.  Stress and the Aging Hippocampus , 1999, Frontiers in Neuroendocrinology.

[25]  H. Farber,et al.  Endothelial cell hypoxic stress proteins. , 1998, The Journal of laboratory and clinical medicine.

[26]  A. Liedtke,et al.  mRNA expression of glycolytic enzymes and glucose transporter proteins in ischemic myocardium with and without reperfusion. , 1998, Journal of molecular and cellular cardiology.

[27]  Í. Lopes-Cendes,et al.  Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. , 1998, Archives of neurology.

[28]  W. Strittmatter,et al.  Glyceraldehyde 3-Phosphate Dehydrogenase Abnormality in Metabolically Stressed Huntington Disease Fibroblasts , 1998, Developmental Neuroscience.

[29]  Lisa Garrett,et al.  Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA , 1998, Nature Genetics.

[30]  C. Sheline,et al.  Neuronal Death in Cultured Murine Cortical Cells Is Induced by Inhibition of GAPDH and Triosephosphate Isomerase , 1998, Neurobiology of Disease.

[31]  M. Dragunow,et al.  Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum , 1998, Neuroscience.

[32]  P. Fürst,et al.  Glyceraldehyde-3-phosphate Dehydrogenase, the Putative Target of the Antiapoptotic Compounds CGP 3466 andR-(−)-Deprenyl* , 1998, The Journal of Biological Chemistry.

[33]  J. Cummings,et al.  Huntington's disease. , 1997, The Psychiatric clinics of North America.

[34]  D. Chuang,et al.  Subcellular Distribution of Glyceraldehyde‐3‐Phosphate Dehydrogenase in Cerebellar Granule Cells Undergoing Cytosine Arabinoside‐Induced Apoptosis , 1997, Journal of neurochemistry.

[35]  S. Snyder,et al.  Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[37]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[38]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[39]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[40]  V. Ferrans,et al.  Reactive oxygen species are downstream mediators of p53-dependent apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Chuang,et al.  Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  K. Fischbeck,et al.  Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. , 1996, Human molecular genetics.

[43]  D. Chuang,et al.  An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. , 1996, The Journal of pharmacology and experimental therapeutics.

[44]  D. Chuang,et al.  A role for GAPDH in apoptosis and neurodegeneration , 1996, Nature Medicine.

[45]  A. Roses,et al.  Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH , 1996, Nature Medicine.

[46]  D. Chuang,et al.  Evidence that Glyceraldehyde‐3‐Phosphate Dehydrogenase Is Involved in Age‐Induced Apoptosis in Mature Cerebellar Neurons in Culture , 1996, Journal of neurochemistry.

[47]  D. Steindler,et al.  DNA End Labeling (TUNEL) in Huntington's Disease and Other Neuropathological Conditions , 1995, Experimental Neurology.

[48]  M. Dragunow,et al.  In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes , 1995, Neuroreport.

[49]  C. Portera-Cailliau,et al.  Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[51]  Christopher A. Ross,et al.  Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease , 1991, Neuroscience Letters.

[52]  R. Perham,et al.  Glyceraldehyde 3-phosphate dehydrogenases: I. The protein chains in glyceraldehyde 3-phosphate dehydrogenase from pig muscle , 1965 .

[53]  M. Abercrombie.  Estimation of nuclear population from microtome sections , 1946, The Anatomical record.

[54]  H. Heinsen,et al.  Cortical and striatal neurone number in Huntington's disease , 2004, Acta Neuropathologica.

[55]  M. Chesselet,et al.  Mouse models of Huntington's disease. , 2002, Trends in pharmacological sciences.

[56]  W. Tatton,et al.  Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. , 2000, Molecular pharmacology.

[57]  W. Tatton,et al.  Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. , 2000, Journal of neural transmission. Supplementum.

[58]  P. Brecher,et al.  Oxidative stress increases glyceraldehyde-3-phosphate dehydrogenase mRNA levels in isolated rabbit aorta. , 1996, The American journal of physiology.